💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Galmed Pharmaceuticals Ltd. (GLMD)
« Back to company indexGLMD Chatter Timeline
Stock Ticker for GLMD
Most Active Tweeters for GLMD
| User | Tweets |
|---|---|
| @AmericanBanking | 2 |
| @HealthcareBeat | 1 |
| @ZolmaxNews | 1 |
| @WeekHerald | 1 |
| @Cozino3 | 1 |
Recent Tweets for GLMD
 |
@Cozino3 $glmd Triggers to come ? Beautiful faling wedge. Invers MACD / RSI versus price. Is MOM breaking with downtrend ? https://t.co/oN5QXSqmEt October 22nd 2020, 11:10am |
 |
@WeekHerald Galmed Pharmaceuticals Ltd. $GLMD Expected to Announce Earnings of -$0.32 Per Share https://t.co/77QDPDooPE October 21st 2020, 3:10pm |
 |
@AmericanBanking Galmed Pharmaceuticals Ltd. $GLMD Expected to Announce Earnings of -$0.32 Per Share https://t.co/WeX9ohFYHj #stocks October 21st 2020, 3:10pm |
 |
@ZolmaxNews Galmed Pharmaceuticals Ltd. $GLMD Sees Significant Decrease in Short Interest https://t.co/SsVUPd9utD October 19th 2020, 8:10am |
 |
@HealthcareBeat New patent application published for: Capsule Dosage Forms of Triamterene, and Process of Preparation Thereof $GLMD https://t.co/ntDLERqNG7 October 17th 2020, 10:10pm |
|
@AmericanBanking Galmed Pharmaceuticals Ltd. $GLMD Short Interest Update https://t.co/8lndAcVTGp #stocks October 17th 2020, 6:10pm |
 |
@orinsway @Sarah_Katilyn I am waiting patiently for $GLMD October 13th 2020, 3:10pm |
 |
@MarcJacksonLA $GLMD Galmed partners with Gannex to develop NASH cure https://t.co/VqYPvIyoEt October 12th 2020, 2:10pm |
 |
@super__traders RT @super_trades: $GLMD valuation ( $TBRA not updated) https://t.co/gEkbnP397Q October 12th 2020, 1:10pm |
 |
@GrnBulls $GLMD Up 4.5% (low vol) October 9th 2020, 10:10am |
 |
@mediasentiment $GLMD new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 1379 October 7th 2020, 7:10pm |
|
@AmericanBanking Galmed Pharmaceuticals $GLMD Stock Price Up 9.8% https://t.co/nYQ7MRWvSp #stocks October 7th 2020, 7:10pm |
 |
@OlympiaReport Analysts Expect Galmed Pharmaceuticals Ltd. $GLMD to Post -$0.32 EPS https://t.co/SuqWBfir2g October 4th 2020, 5:10pm |
|
@AmericanBanking Galmed Pharmaceuticals Ltd $GLMD Receives Average Recommendation of “Buy” from Brokerages https://t.co/3CZLAPsO1B #stocks September 30th 2020, 1:09am |
|
@HealthcareBeat New patent application published for: Dosing Appratus for Dispensing a Fluid Under Aseptic Conditions $GLMD https://t.co/fTFwT352XR September 26th 2020, 1:09pm |
|
@HealthcareBeat A Comparative Study of Selatogrel Formulations in Healthy Subjects - NCT04557280 $GLMD https://t.co/m046uePuOO September 19th 2020, 1:09pm |
 |
@Sarah_Katilyn $GLMD another bio that tickles my pickle https://t.co/JSQzThwxvv https://t.co/tGjiOLwoxi https://t.co/USydOiXLIj September 13th 2020, 9:09pm |
|
@AmericanBanking Galmed Pharmaceuticals Ltd $GLMD Short Interest Update https://t.co/eljeVGgaTz #stocks September 13th 2020, 4:09am |
 |
@ConsumerFeed Galmed Pharmaceuticals Ltd $GLMD Short Interest Update https://t.co/eiQiXTq7xd September 13th 2020, 4:09am |
|
@HealthcareBeat Galmed and Gannex Expand Development Programs For NASH Through Research Collaboration of Aramchol and ASC41 $GLMD https://t.co/Pr0SFvsSJ0 September 11th 2020, 5:09am |
 |
@preticks Latest headline: $GLMD: Galmed and Gannex Expand Development Programs For NASH Through Research Collaboration of Ar… https://t.co/cRLmkHLMwJ September 10th 2020, 9:09am |
 |
@sbwcws Galmed and Ascletis Pharma's Gannex partner to develop NASH combination $GLMD $ASCLF September 10th 2020, 8:09am |
 |
@bthefirsttoknow $GLMD Galmed and Gannex Expand Development Programs For NASH Through Research Collaboration of Aramchol and ASC41 (… https://t.co/0yNLd0rcdG September 10th 2020, 8:09am |
 |
@stock_titan $GLMD Galmed and Gannex Expand Development Programs For NASH Through Research Collaboration of Aramchol and ASC41 (… https://t.co/6Us9jFsiyI September 10th 2020, 8:09am |
|
@HealthcareBeat Form 6-K (report of foreign issuer [rules 13a-16 and 15d-16]) filed with the SEC $GLMD https://t.co/7J0M5LpXW8 September 9th 2020, 10:09am |
 |
@EdgarInsider Alert / Form 6-K filed with the SEC $GLMD #GalmedPharmaceuticals Ltd https://t.co/sdKBS8mftG September 9th 2020, 10:09am |
 |
@FlashAlert_me $GLMD [15s. delayed] filed form 6-K on September 09, 10:03:56 https://t.co/XIoFUtK0ZD September 9th 2020, 10:09am |
 |
@AlertTrade MOST ACTIVE: $GLMD Galmed Pharmaceuticals Ltd ? TradeIdeas via ? https://t.co/VS8RO1bzXJ September 9th 2020, 10:09am |
|
@HealthcareBeat Galmed collaborates with Gannex Pharma for development programs in NASH $GLMD https://t.co/QXBYJCKucR September 9th 2020, 7:09am |
 |
@MarketCurrents $GLMD $ASCLF - Galmed collaborates with Gannex Pharma for development programs in NASH https://t.co/9yjMWQIrl7 September 9th 2020, 7:09am |
|
@FlashAlert_me $GLMD [15s. delayed]: Issued Press Release on September 09, 06:30:00: Gannex and Galmed Expand Development Programs… https://t.co/QCB2TOGA2y September 9th 2020, 6:09am |
|
@preticks RT @preticks: Latest headline: $GLMD: Gannex and Galmed Expand Development Programs For NASH Through Research Collaboration of Aramchol and… September 9th 2020, 6:09am |
|
@preticks Latest headline: $GLMD: Gannex and Galmed Expand Development Programs For NASH Through Research Collaboration of Ar… https://t.co/2tlqGD2QvM September 9th 2020, 6:09am |
|
@ConsumerFeed Brokerages Set Galmed Pharmaceuticals Ltd $GLMD PT at $18.00 https://t.co/lgpxi9RJgG September 8th 2020, 8:09am |
 |
@WatchlistN Zacks: Brokerages Anticipate Galmed Pharmaceuticals Ltd $GLMD Will Post Earnings of -$0.32 Per Share https://t.co/Ea4EU5SHfJ September 8th 2020, 5:09am |
 |
@ThisLincolnian Zacks: Brokerages Anticipate Galmed Pharmaceuticals Ltd $GLMD Will Post Earnings of -$0.32 Per Share https://t.co/CIV8dtjB7C September 8th 2020, 5:09am |
 |
@maxm_profit RT @AmericanBanking: Zacks: Analysts Anticipate Galmed Pharmaceuticals Ltd $GLMD to Announce -$0.32 EPS https://t.co/XIGNDbNnke #stocks September 6th 2020, 6:09pm |
 |
@CFinancialNews Zacks: Analysts Anticipate Galmed Pharmaceuticals Ltd $GLMD to Announce -$0.32 EPS https://t.co/OpQ8cTHzeu #markets September 5th 2020, 8:09pm |
|
@AmericanBanking Zacks: Analysts Anticipate Galmed Pharmaceuticals Ltd $GLMD to Announce -$0.32 EPS https://t.co/XIGNDbNnke #stocks September 5th 2020, 8:09pm |
|
@ZolmaxNews Galmed Pharmaceuticals Ltd $GLMD Receives Consensus Rating of “Buy” from Brokerages https://t.co/MXyqEgvdzY September 5th 2020, 3:09am |
 |
@StockRoboto Daily Stock SMA strategy trend investing Report: These stocks are trending upwards: $GLMD, $PETQ These stocks are… https://t.co/DZLJiEhfWt August 26th 2020, 10:08am |
 |
@dailypoliticaln Galmed Pharmaceuticals $GLMD Shares Cross Above 50 Day Moving Average of $4.77 https://t.co/HQPd70lgRq August 23rd 2020, 4:08am |
 |
@TheMarketsDaily Galmed Pharmaceuticals $GLMD Share Price Passes Above Fifty Day Moving Average of $4.77 https://t.co/RmQYZ7XRiH August 23rd 2020, 4:08am |
|
@AmericanBanking Galmed Pharmaceuticals $GLMD Shares Pass Above 50 Day Moving Average of $4.77 https://t.co/HVGYJVQCKA #stocks August 22nd 2020, 3:08am |
 |
@TranscriptDaily Brokerages Anticipate Galmed Pharmaceuticals Ltd $GLMD to Announce -$0.32 Earnings Per Share https://t.co/JgTanEuSaZ August 18th 2020, 11:08am |
 |
@bbnsnews Brokerages Expect Galmed Pharmaceuticals Ltd $GLMD to Post -$0.32 EPS https://t.co/z9od3hbqDj August 18th 2020, 11:08am |
|
@WeekHerald Brokerages Set Galmed Pharmaceuticals Ltd $GLMD Target Price at $19.63 https://t.co/DqfW3ucBpr August 16th 2020, 4:08pm |
|
@ConsumerFeed Galmed Pharmaceuticals $GLMD Raised to Buy at Zacks Investment Research https://t.co/otPykop5sX August 16th 2020, 2:08am |
|
@mediasentiment $GLMD new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 2806 August 16th 2020, 1:08am |
|
@ZolmaxNews Galmed Pharmaceuticals $GLMD Raised to Buy at Zacks Investment Research https://t.co/PZ2fJBgm9f August 16th 2020, 1:08am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2020. All rights reserved.
Get the DrugPatentWatch Daily Briefing
Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …
- ✓ Patent Expirations and Generic Entry
- ✓ 505(b)(2) & Biosimilars
- ✓ Insightful Articles and Case Studies
- ✓ Patent Litigation & Challenges
- ✓ Industry Trends
